It was previously shown that an ovariectomy (OVX) prevents pituitaryhyperplasia in Drd2-/- and hCGβ+ female mice, indicating theparticipation of ovarian factors in the development of prolactinoma.However, a hormone replacement with estradiol after OVX does notrestore tumor development.Fil: Faraoni, Erika Yanil. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Abeledo Machado, Alejandra Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto...
The aim of the present work was to study whether immunocytochemical parameters present in the normal...
Prolactin (PRL) modulates the expression of the LH receptor in the ovary and, thus, the cascades of ...
Objective: Estrogen replacement therapy remains current as a therapeutic approach to treat menopaus...
Among all the hormone-secreting pituitary tumours, prolactinomas are the mostfrequently found in the...
Ovarian cancer is thought to be derived from the ovarian surface epithelium (OSE), but it is often d...
The etiology of pituitary adenomas remains largely unknown, with the exception of involvement of est...
The most common and deadly form of ovarian cancer is High-Grade Serous Ovarian Carcinoma (HGSOC). Mo...
Female infertility is often associated with deregulation of hormonal networks, and hyperprolactinemi...
The development of genetically modified animals has been useful to understand the mechanisms involve...
"L'article est publié par l'American Physiological Society"Transgenic female mice overexpressing the...
Dopamine receptor type 2 (D2R) knockout mice (KO) have chronic hyperprolactinemia, pituitary hyperpl...
Dopamine and estradiol interact in the regulation of lactotroph cell proliferation and prolactin sec...
In previous studies, we assessed the effects of intrapituitary injection of a recombinant adenoviral...
Prolactin (PRL) is a key player in the development of mammary cancer. We studied the effects of pari...
Background: The implementation of gene therapy for the treatment of pituitary tumors emerges as a pr...
The aim of the present work was to study whether immunocytochemical parameters present in the normal...
Prolactin (PRL) modulates the expression of the LH receptor in the ovary and, thus, the cascades of ...
Objective: Estrogen replacement therapy remains current as a therapeutic approach to treat menopaus...
Among all the hormone-secreting pituitary tumours, prolactinomas are the mostfrequently found in the...
Ovarian cancer is thought to be derived from the ovarian surface epithelium (OSE), but it is often d...
The etiology of pituitary adenomas remains largely unknown, with the exception of involvement of est...
The most common and deadly form of ovarian cancer is High-Grade Serous Ovarian Carcinoma (HGSOC). Mo...
Female infertility is often associated with deregulation of hormonal networks, and hyperprolactinemi...
The development of genetically modified animals has been useful to understand the mechanisms involve...
"L'article est publié par l'American Physiological Society"Transgenic female mice overexpressing the...
Dopamine receptor type 2 (D2R) knockout mice (KO) have chronic hyperprolactinemia, pituitary hyperpl...
Dopamine and estradiol interact in the regulation of lactotroph cell proliferation and prolactin sec...
In previous studies, we assessed the effects of intrapituitary injection of a recombinant adenoviral...
Prolactin (PRL) is a key player in the development of mammary cancer. We studied the effects of pari...
Background: The implementation of gene therapy for the treatment of pituitary tumors emerges as a pr...
The aim of the present work was to study whether immunocytochemical parameters present in the normal...
Prolactin (PRL) modulates the expression of the LH receptor in the ovary and, thus, the cascades of ...
Objective: Estrogen replacement therapy remains current as a therapeutic approach to treat menopaus...